Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Equity Bottom-Up

<ul><li>Herbalife’s updated investor presentation reinforces an evolving thesis focused on the combination of a resilient global distribution infrastructure and an expanding personalized nutrition platform. </li><li>Management highlighted its position as the world’s #1 protein shake brand, supported by ~6.4 million members, ~63,000 Nutrition Clubs, and operations across 95 markets.</li><li>The company continues to view its distributor network and Nutrition Club ecosystem as a durable competitive advantage that is difficult to replicate.</li></ul>

Herbalife’s updated investor presentation reinforces an evolving thesis focused on the combination of a resilient global distribution infrastructure and an expanding personalized nutrition platform. Management highlighted its position as the world’s #1 protein shake brand, supported by ~6.4 million members, ~63,000 Nutrition Clubs, and operations across 95 markets.The company continues to view its distributor network and Nutrition Club ecosystem as a durable competitive advantage that is difficult to replicate.

HLF: Personalized Nutrition Strategy Takes Center Stage

<div><ul><li>HLF reported 1Q26 results that were in line with its April pre-announcement and above original guidance. </li><li>The company raised the midpoints of its FY26 constant-currency net sales growth and adjusted EBITDA outlook.</li><li>1Q26 adjusted EPS was $0.64 versus $0.59 in the year-ago quarter, up 8.5%, and above FactSet consensus of $0.57. Management does not provide guidance for adjusted EPS.</li></ul></div>

HLF reported 1Q26 results that were in line with its April pre-announcement and above original guidance. The company raised the midpoints of its FY26 constant-currency net sales growth and adjusted EBITDA outlook.1Q26 adjusted EPS was $0.64 versus $0.59 in the year-ago quarter, up 8.5%, and above FactSet consensus of $0.57. Management does not provide guidance for adjusted EPS.

HLF: India Drives Another Beat as Personalization Platform Takes Shape

<div><ul><li>HLF preannounced 1Q26 sales and adjusted EBITDA above consensus and updated its debt refinancing plans.</li><li>1Q26 reported dollar sales are now expected to be up 7.5-8.0% Y/Y, above HLF’s previous expectations of 3.0-7.0% and FactSet consensus of 5.0%.</li><li>Constant currency sales are now expected to be up 5.0-5.5%, above the company’s previous expectations of 0.5%-4.5%.</li></ul></div>

HLF preannounced 1Q26 sales and adjusted EBITDA above consensus and updated its debt refinancing plans.1Q26 reported dollar sales are now expected to be up 7.5-8.0% Y/Y, above HLF’s previous expectations of 3.0-7.0% and FactSet consensus of 5.0%.Constant currency sales are now expected to be up 5.0-5.5%, above the company’s previous expectations of 0.5%-4.5%.

HLF: 1Q26 Upside Preannounced; Debt Refinancing Could Meaningfully Improve Financial Profile

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

<ul><li>Herbalife has taken a notable step in its effort to reposition itself from a traditional supplement seller into a more technology-enabled wellness platform through an agreement to acquire certain assets from Bioniq, a UK-based personalized supplements company.</li><li>The transaction, announced with a planned purchase price of $55 million paid over five years plus up to $95 million in contingent payments, is expected to close in the second quarter of 2026, subject to customary conditions and approvals.</li><li>Herbalife has framed the deal as part of a broader strategy to deepen its capabilities in data-driven nutrition, following earlier moves involving Pro2col and Link BioSciences.</li></ul>

Herbalife has taken a notable step in its effort to reposition itself from a traditional supplement seller into a more technology-enabled wellness platform through an agreement to acquire certain assets from Bioniq, a UK-based personalized supplements company.The transaction, announced with a planned purchase price of $55 million paid over five years plus up to $95 million in contingent payments, is expected to close in the second quarter of 2026, subject to customary conditions and approvals.Herbalife has framed the deal as part of a broader strategy to deepen its capabilities in data-driven nutrition, following earlier moves involving Pro2col and Link BioSciences.

Herbalife Takeover Move Into Bioniq Signals A Bold Shift Toward Personalized Nutrition!

<div><ul><li>HLF announced an agreement to acquire certain assets from Bioniq, a UK-based personalized supplements company, for a base purchase price of $55 million paid over five years, with an initial payment of $10 million at closing. </li><li>Additionally, there are up to $95 million in contingent payments tied to future performance of Bioniq based on up to $1 billion of Bioniq-specific product sales. </li><li>The structure is cash-light and performance-linked, consistent with management’s stated acquisition philosophy.</li></ul></div>

HLF announced an agreement to acquire certain assets from Bioniq, a UK-based personalized supplements company, for a base purchase price of $55 million paid over five years, with an initial payment of $10 million at closing. Additionally, there are up to $95 million in contingent payments tied to future performance of Bioniq based on up to $1 billion of Bioniq-specific product sales. The structure is cash-light and performance-linked, consistent with management’s stated acquisition philosophy.

HLF: Bioniq Acquisition Expands Personalized Nutrition Platform

United States

Herbalife Ltd. is a global nutrition company that sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products as well as personal care products. The Company distributes and sells its products through a network of independent distributors, using the direct selling channel.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Herbalife Ltd (HLF US)

HLF: Personalized Nutrition Strategy Takes Center Stage

The company continues to view its distributor network and Nutrition Club ecosystem as a durable competitive advantage that is difficult to replicate.

Water Tower Research

HLF: India Drives Another Beat as Personalization Platform Takes Shape

1Q26 adjusted EPS was $0.64 versus $0.59 in the year-ago quarter, up 8.5%, and above FactSet consensus of $0.57. Management does not provide...

Water Tower Research

HLF: 1Q26 Upside Preannounced; Debt Refinancing Could Meaningfully Improve Financial Profile

1Q26 reported dollar sales are now expected to be up 7.5-8.0% Y/Y, above HLF’s previous expectations of 3.0-7.0% and FactSet consensus of 5.0%.

Water Tower Research

Herbalife Takeover Move Into Bioniq Signals A Bold Shift Toward Personalized Nutrition!

Herbalife has taken a notable step in its effort to reposition itself from a traditional supplement seller into a more technology-enabled wellness...

Baptista Research

HLF: Bioniq Acquisition Expands Personalized Nutrition Platform

HLF announced an agreement to acquire certain assets from Bioniq, a UK-based personalized supplements company, for a base purchase price of $55...

Water Tower Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)